Target intelligence / Profile preview

DNA cross-link (ICL) (ICL)

Target
ICL
Molecular classification
Nucleic acid, DNA lesion
01

Overview

DNA cross-links are covalent chemical bonds that form between two nucleotides in a DNA molecule, occurring either on the same strand (intrastand) or between opposing strands (interstrand cross-links or ICLs) (Source: PubMed PMC3100973). These lesions are highly cytotoxic because they prevent the DNA double helix from unwinding, thereby stalling essential cellular processes such as DNA replication and transcription (Source: Nature Reviews Molecular Cell Biology). In clinical oncology, DNA cross-linking is a validated therapeutic strategy; several classes of chemotherapy, including platinum-based agents and nitrogen mustards, exert their anti-tumor effects by inducing these lesions (Source: StatPearls). The resulting DNA damage triggers cell cycle arrest and apoptosis, particularly in rapidly proliferating malignant cells (Source: NCI Drug Dictionary). However, the efficacy of these drugs is often limited by cellular DNA repair mechanisms, such as the Fanconi anemia pathway and nucleotide excision repair, which can remove the cross-links and lead to chemoresistance (Source: Nature Reviews Cancer). Furthermore, because these agents are not site-specific, they can cause significant systemic toxicity and increase the risk of secondary cancers (Source: PubMed PMC4113511).

Other names
Interstrand cross-linkIntrastand cross-linkDNA-DNA crosslinkDNA adductDNA lesion
02

Mechanism of action

Induction of covalent linkages between DNA strands (interstrand) or within a single strand (intrastand), which physically prevents the separation of the DNA double helix, thereby blocking replication and transcription and inducing apoptosis (Source: StatPearls, PubMed PMC3100973).

03

Biological functions

DNA replicationDNA transcriptionDNA repairApoptosisCell cycle arrest
04

Disease associations

CancerFanconi anemia
05

Safety considerations

MyelosuppressionNephrotoxicityOtotoxicityPeripheral neuropathySecondary malignanciesGonadal toxicity
06

Interacting drugs

Cisplatin

11 more in the full profile.

07

Biomarkers

ERCC1BRCA1BRCA2FANCAFANCCFANCGγH2AXp53

Beyond the preview

Go deeper on DNA cross-link (ICL) (ICL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA cross-link (ICL) (ICL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call